Loading…
Operates in Pharma — Distribution. Per the activity note to the FY2024 annual report, the company carries out wholesale trade in pharmaceutical products.
| Line item | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|
| 10,134 | 11,128 | 15,588 | +24.0% | |
| Total COGS | 6,104 | 6,410 | 9,121 | +22.2% |
| Gross Profit | 4,029 | 4,717 | 6,467 | +26.7% |
| Gross Margin | 39.8% | 42.4% | 41.5% | |
| 3,299 | 3,787 | 1,404 | -34.8% | |
| EBITDA | 730 | 931 | 5,063 | +163.3% |
| EBITDA Margin | 7.2% | 8.4% | 32.5% | |
| Total D&A | 14 | 14 | 20 | +21.2% |
| EBIT / Operating Income | 717 | 917 | 5,043 | +165.3% |
| Total Interest Expense | 0 | 11 | 4 | -58.2% |
| Total Other Income | 457 | 619 | 141 | -44.5% |
| Profit Before Tax | 1,174 | 1,525 | 5,179 | +110.1% |
| Total Income Tax | 0 | 0 | 0 | |
| Net Profit / (Loss) | 1,174 | 1,525 | 5,179 | +110.1% |
| Net Margin | 11.6% | 13.7% | 33.2% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →